HIV-ASSOCIATED CANCERS

Clinical trials for HIV-ASSOCIATED CANCERS explained in plain language.

Never miss a new study

Get alerted when new HIV-ASSOCIATED CANCERS trials appear

Sign up with your email to follow new studies for HIV-ASSOCIATED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope: testing powerful cancer drugs for people with HIV

Disease control Terminated

This early-stage study tested the safety and best dose of two immunotherapy drugs, nivolumab and ipilimumab, for people living with HIV who also have advanced cancers like Hodgkin lymphoma, Kaposi sarcoma, or lung cancer. The goal was to see if these drugs, which help the immune …

Matched conditions: HIV-ASSOCIATED CANCERS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

HIV-ASSOCIATED CANCERS

Get alerted when new HIV-ASSOCIATED CANCERS trials appear

New hope: testing powerful cancer drugs for people with HIV